Published in Vaccine Weekly, May 14th, 2003
The facility also has Biological Safety Level (BSL) three laboratories to accommodate work with microorganisms that must be specially contained.
The GMP facility, which meets standards of operation established by the U.S. Food and Drug Administration (FDA), will allow the research center to produce such products as the three-tiered AIDS vaccine currently under development at St. Jude, as well as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.